Orion Infusion Limited (DSE: ORIONINFU)
Bangladesh
· Delayed Price · Currency is BDT 378.50
+29.10 (8.33%)
At close: Sep 12, 2024
Orion Infusion Income Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2014 |
| Revenue | 850.39 | 810.15 | 829.57 | 727.4 | 740.87 | 810.3 | Upgrade
|
| Revenue Growth (YoY) | 3.12% | -2.34% | 14.05% | -1.82% | -8.57% | 7.50% | Upgrade
|
| Cost of Revenue | 508.52 | 483.93 | 490.03 | 430.36 | 439.75 | 483.81 | Upgrade
|
| Gross Profit | 341.87 | 326.23 | 339.54 | 297.04 | 301.12 | 326.49 | Upgrade
|
| Selling, General & Admin | 259.21 | 247.8 | 246.98 | 215.97 | 224.12 | 247.08 | Upgrade
|
| Operating Expenses | 259.21 | 247.8 | 246.98 | 215.97 | 224.12 | 247.08 | Upgrade
|
| Operating Income | 82.66 | 78.43 | 92.56 | 81.07 | 76.99 | 79.41 | Upgrade
|
| Interest Expense | -30.62 | -27.19 | -26.64 | -26.3 | -37.5 | -30.15 | Upgrade
|
| Interest & Investment Income | 0.23 | 0.21 | 0.35 | 0.15 | 0.38 | 0.24 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.96 | -1.11 | -1.77 | -0.85 | -1.16 | 0.7 | Upgrade
|
| EBT Excluding Unusual Items | 51.31 | 50.34 | 64.5 | 54.07 | 38.72 | 50.19 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.04 | -0.04 | 0.82 | -1.77 | -0.03 | -0.04 | Upgrade
|
| Pretax Income | 51.26 | 50.3 | 65.32 | 52.3 | 38.69 | 50.15 | Upgrade
|
| Income Tax Expense | 8.56 | 8.4 | 22.5 | 24.42 | 9 | 10.07 | Upgrade
|
| Net Income | 42.7 | 41.9 | 42.82 | 27.88 | 29.7 | 40.09 | Upgrade
|
| Net Income to Common | 42.7 | 41.9 | 42.82 | 27.88 | 29.7 | 40.09 | Upgrade
|
| Net Income Growth | 0.62% | -2.15% | 53.57% | -6.10% | -25.92% | 21.31% | Upgrade
|
| Shares Outstanding (Basic) | 20 | 20 | 20 | 20 | 20 | 20 | Upgrade
|
| Shares Outstanding (Diluted) | 20 | 20 | 20 | 20 | 20 | 20 | Upgrade
|
| EPS (Basic) | 2.10 | 2.06 | 2.10 | 1.37 | 1.46 | 1.97 | Upgrade
|
| EPS (Diluted) | 2.10 | 2.06 | 2.10 | 1.37 | 1.46 | 1.97 | Upgrade
|
| EPS Growth | 0.62% | -2.15% | 53.57% | -6.10% | -25.92% | 21.31% | Upgrade
|
| Free Cash Flow | 38.9 | -7.25 | 26.01 | 6.42 | 45.65 | 54.49 | Upgrade
|
| Free Cash Flow Per Share | 1.91 | -0.36 | 1.28 | 0.32 | 2.24 | 2.68 | Upgrade
|
| Dividend Per Share | 1.000 | 1.000 | 2.000 | 1.000 | 1.000 | - | Upgrade
|
| Dividend Growth | -50.00% | -50.00% | 100.00% | 0% | - | - | Upgrade
|
| Gross Margin | 40.20% | 40.27% | 40.93% | 40.84% | 40.64% | 40.29% | Upgrade
|
| Operating Margin | 9.72% | 9.68% | 11.16% | 11.15% | 10.39% | 9.80% | Upgrade
|
| Profit Margin | 5.02% | 5.17% | 5.16% | 3.83% | 4.01% | 4.95% | Upgrade
|
| Free Cash Flow Margin | 4.57% | -0.90% | 3.14% | 0.88% | 6.16% | 6.72% | Upgrade
|
| EBITDA | 95.08 | 93.82 | 103.03 | 91.16 | 95.65 | 105.1 | Upgrade
|
| EBITDA Margin | 11.18% | 11.58% | 12.42% | 12.53% | 12.91% | 12.97% | Upgrade
|
| D&A For EBITDA | 12.42 | 15.39 | 10.47 | 10.09 | 18.66 | 25.7 | Upgrade
|
| EBIT | 82.66 | 78.43 | 92.56 | 81.07 | 76.99 | 79.41 | Upgrade
|
| EBIT Margin | 9.72% | 9.68% | 11.16% | 11.15% | 10.39% | 9.80% | Upgrade
|
| Effective Tax Rate | 16.70% | 16.70% | 34.45% | 46.69% | 23.25% | 20.07% | Upgrade
|
| Advertising Expenses | - | 2.67 | 3.11 | 2.74 | 2.6 | 3 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.